Doximity Cash Flow Statement
DOCS / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | - | $223.2M | $147.6M | $112.8M | $154.8M | $50.2M | $29.7M |
| Depreciation & Amortization | - | $10.7M | $10.3M | $10.3M | $5.0M | $3.7M | $900.0K |
| Operating Cash Flow | - | $273.3M | $184.1M | $179.6M | $126.6M | $83.0M | $26.2M |
| Capital Expenditures | - | $0 | $147.0K | $1.7M | $1.9M | $245.0K | $285.0K |
| Free Cash Flow | - | $273.3M | $183.9M | $177.9M | $124.7M | $82.7M | $25.9M |
| Share Buybacks | - | $120.3M | $280.7M | $85.3M | $2.7M | $2.0M | $0 |
| FCF Margin | - | 47.9% | 38.7% | 42.4% | 36.3% | 40.0% | 22.3% |